Evaluating respiratory syncytial virus immunization strategies for infants in Canada: A cost-utility analysis
Gebremedhin B Gebretekle, Marie Lan, Min Xi, Raphael Ximenes, Sarah A Buchan, Elissa M Abrams, Melissa K Andrew, Nicholas Brousseau · 2026
Read Evaluating respiratory syncytial virus immunization strategies for infants in Canada: A cost-utility analysis by Gebremedhin B Gebretekle, Marie Lan, Min Xi, Raphael Ximenes, Sarah A Buchan, Elissa M Abrams, Melissa K Andrew, Nicholas Brousseau (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0351183.txt.
Description
Respiratory syncytial virus sends many Canadian babies to hospital each winter, and new long-acting antibody shots plus a pregnancy vaccine have widened prevention choices. Gebremedhin B Gebretekle and colleagues compared seven seasonal programs for cost and health gain, in this 2026 PLOS One analysis.
Their model weighed health system and wider social costs against years of healthy life, using a standard value threshold. A combined approach came out best: vaccinate mothers due during virus season, and give antibody shots to other infants. Rankings shifted with product prices, the authors note, so the cheapest sensible program depends on deals governments strike with makers.
Catalog record
| CREATOR | Gebremedhin B Gebretekle, Marie Lan, Min Xi, Raphael Ximenes, Sarah A Buchan, Elissa M Abrams, Melissa K Andrew, Nicholas Brousseau |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 38314 |
| LICENSE | CC_BY |
| RIGHTS | CC BY |
| SOURCE | PLOS |